ENTERO
Entero Healthcare Solutions Limited
NSE BSELast Traded Price
₹2089
63.6 (3.14%)
Open
₹2049
High
₹2137.6
Low
₹1965.6
Prev Close
₹2025.4
Industry
Pharmacy Retail
Market Cap
9213.82 Cr
Filing History
Recent corporate announcements and filings for ENTERO
Business Update
Neutral
2026-11-05 19:59
- Entero Healthcare Solutions has made available the audio recording of its Q2 and H1 FY27 earnings conference call on its website.
- The call transcript will be submitted to the stock exchanges and uploaded on the website in due course.
Business Update
Neutral
2026-11-05 19:32
- Audio recording of the Earnings Call held for Q2 and H1 ended September 30, 2026, is now available on the company's website.
- Transcript of the earnings call will be shared with the exchanges in due course.
Business Update
Positive
2026-11-04 22:17
- Q2 FY27 Revenue grew 33% YoY to ₹2,087.1 Cr.
- EBITDA increased 78% YoY to ₹110.7 Cr with EBITDA margin at 5.3% (+135 bps YoY).
- Consolidated PAT rose 66% YoY to ₹60.7 Cr.
- Management highlighted strong organic growth and remains on track to comfortably achieve full-year guidance.
Business Update
Negative
2026-11-04 22:16
- Entero Healthcare Solutions informed that its wholly owned subsidiary, Vasavi Medicare Solutions Private Limited, faced a payment default of INR 11.87 crore from a customer, M/s. S M Pharma.
- Vasavi has made a full provision for the outstanding amount in its books.
- Vasavi is initiating legal proceedings for recovery of the dues.
Financials
Positive
2026-11-04 20:36
Q2 FY27 Consolidated Revenue ₹2,087.1Cr vs ₹1,570.9Cr (▲33% YoY)
EBITDA ₹110.7Cr vs ₹62.1Cr (▲78% YoY)
PAT ₹60.7Cr vs ₹36.6Cr (▲66% YoY)
EBITDA Margin 5.3% vs 4.0% (▲135bps)
Financials
Neutral
2026-11-04 20:22
Q2 FY27 Consolidated Revenue ₹2,087.08Cr vs ₹1,570.95Cr (▲32.9% YoY)
EBITDA ₹110.66Cr vs ₹62.07Cr (▲78.3% YoY)
PAT ₹60.74Cr vs ₹36.60Cr (▲66.0% YoY)
EBITDA Margin 5.30% vs 3.95% (▲135bps)